ND040-42
N/A
Report date: 2022/01/14 13:23:58
Base Information
Drug NameND040-42
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim International GmbhNumab Therapeutics Ag
China Registration ClassN/A
Develop Information
Active CompaniesBoehringer Ingelheim International GmbhNumab Therapeutics Ag
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A